Lentiviral gene therapy for X-linked chronic granulomatous disease is a research paper published in Nature Medicine (2020). On theSindex it has a DataRank of 0.832. It has been cited 256 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.832
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →CCR NIH HHS
Grant: HHSN261200800001C
Wellcome Trust
Grant: 104807
Refinement of gene and cell therapies for inherited immunodeficiencies based on human interventions and developing technologies .
NCI NIH HHS
Grant: HHSN261200800001E
NCI NIH HHS
Grant: K08 CA201591
Wellcome Trust
Grant: 104807/Z/14/Z
National Health and Medical Research Council (NHMRC)
Grant: 418021
Chromatin-based mechanisms of retrotransposon sliencing and Maintenance of Genomic stability
European Commission
Grant: 305011
Gene Therapy for X-linked Chronic Granulomatous Disease (CGD)
Orchard Therapeutics
Borchard Foundation Center on Law and Aging
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals